Key result
Short-term spinal cord stimulation therapy increased global myocardial perfusion reserve from 1.7 at baseline to 2.0 in patients with refractory angina pectoris.
Why the study?
Does short-term spinal cord stimulation improve myocardial ischaemia tolerance and myocardial perfusion reserve in patients with refractory angina pectoris?
Observational (n=18)
Does short-term spinal cord stimulation improve myocardial ischaemia tolerance and myocardial perfusion reserve in patients with refractory angina pectoris?
Short-term spinal cord stimulation improves myocardial perfusion reserve and endothelium-mediated vasomotor function in patients with refractory angina pectoris, suggesting alleviation of perfusion abnormalities.
Answers are grounded in this paper and cite their sources.
Short-term SCS may improve perfusion reserve in refractory angina; hypothesis-generating and requires randomized confirmation before practice change.
AIMS: Epidural spinal cord stimulation (SCS) provides symptom relief in refractory angina pectoris, but its mechanism of action remains incompletely understood. We studied effects of short-term SCS therapy on myocardial ischaemia tolerance, myocardial perfusion reserve (MPR), and endothelium-mediated vasodilatation induced by cold pressor test (CPT) in patients with refractory angina pectoris. METHODS AND RESULTS: We prospectively recruited 18 patients with refractory angina pectoris and studied them after implantation of SCS device at baseline before starting the therapy and after 3 weeks of continuous SCS therapy. Myocardial ischaemia was evaluated by dobutamine stress echocardiography. Global and regional myocardial blood flow (MBF) were measured using positron emission tomography and (15)O-water at rest, during adenosine stress, and in response to CPT. Systemic haemodynamics were comparable before and after 3 weeks of SCS at rest, during adenosine stress and during CPT. Appearance of angina pectoris induced by dobutamine stress was delayed after SCS therapy. Global MPR increased (P = 0.02) from 1.7 ± 0.6 at baseline to 2.0 ± 0.6 after 3-week SCS therapy. This was associated with a significant reduction in global MBF at rest and increase in MBF induced by adenosine in the ischaemic regions. Global MBF response to CPT was improved after SCS (0.27 ± 0.20 vs. 0.40 ± 0.15, P = 0.03). CONCLUSION: Short-term SCS therapy improved myocardial ischaemia tolerance, absolute MPR, and endothelium-mediated vasomotor function in refractory angina pectoris, indicating that this therapy can alleviate myocardial perfusion abnormalities in advanced CAD.
No takes yet. Share an insight, caveat, or question.
Saraste et al. (2014) conducted an observational in refractory angina pectoris (n=18). Epidural spinal cord stimulation (SCS) vs. Baseline (before starting therapy) was evaluated on Global myocardial perfusion reserve (MPR) (p=0.02). Short-term spinal cord stimulation therapy increased global myocardial perfusion reserve from 1.7 at baseline to 2.0 in patients with refractory angina pectoris.
Synapse has enriched 10 related papers. Consider them for comparative context: